Home / Companies / Cure Stat Rx Home Infusion And Specialty Pharmacy / Trends
Cure Stat Rx Home Infusion And Specialty Pharmacy H-1B trends
Quarterly LCA aggregate trend points for Cure Stat Rx Home Infusion And Specialty Pharmacy. Each point carries filing counts, distinct employers, distinct role titles, SOC coverage, wage metrics, certification counts, and source IDs when returned.
Summary
H-1B LCA filings for Cure Stat Rx Home Infusion And Specialty Pharmacy span 2019 Q2 to 2022 Q3, peaking at 5 filings in 2019 Q2.
The most recent reported period (2022 Q3) shows 2 filings.
LCA filings are labor-condition applications certified by the U.S. Department of Labor, not active job postings or approved USCIS H-1B petitions.
| Period | LCA count | Role titles | SOC codes | Avg wage low | Avg prevailing | Certified | Certification rate |
|---|---|---|---|---|---|---|---|
| 2019 Q2 | 5 | 1 | 1 | $106,400 | $103,135 | 2 | 40.0% |
| 2022 Q3 | 2 | 1 | 1 | $129,500 | $129,126 | 2 | 100.0% |
Frequently asked questions
- How have H-1B filings for Cure Stat Rx Home Infusion And Specialty Pharmacy changed over time?
- H-1B LCA filings for Cure Stat Rx Home Infusion And Specialty Pharmacy span 2019 Q2 to 2022 Q3, peaking at 5 filings in 2019 Q2. The most recent reported period (2022 Q3) shows 2 filings. LCA filings are labor-condition applications certified by the U.S. Department of Labor, not active job postings or approved USCIS H-1B petitions.
Get this page with API
Rendered from the bluedoor H-1B Jobs API. Reproduce it:
GET https://api.bluedoor.sh/h1b-jobs/v1/trends?company=cure+stat+rx+home+infusion+and+specialty+pharmacy&metric=lca_countJSON